Norton W T, Cammer W, Bloom B R, Gordon S
Adv Exp Med Biol. 1978;100:365-81. doi: 10.1007/978-1-4684-2514-7_26.
In the inflammatory demyelinating diseases, such as multiple sclerosis, Landry-Guillain-Barré syndrome and experimental allergic encephalomyelitis, demyelination occurs in the vicinity of infiltrating mononuclear cells. Although the histopathology is characteristic of each disease, the general observation that myelin destruction in inflammatory lesions begins prior to phagocytosis suggests a common mechanism for myelinolysis in these diseases. Recent studies show that stimulated macrophages secrete several neutral proteinases, including plasminogen (Plg) activator. We have tested the possibility that these proteinases could, directly or indirectly, initiate myelin destruction. Isolated brain myelin was incubated with supernatant media from cultures of stimulated mouse peritoneal macrophages in the presence and absence of Plg. Cell supernatants alone caused some degradation of basic protein (BP) in myelin. The amount degraded was considerably enhanced in the presence of Plg. The other myelin proteins remained essentially intact. While the Plg-independent proteolytic activity in the supernatants was abolished by EDTA, known to inhibit the neutral proteinases, the Plg-dependent hydrolysis was inhibited by p-nitrophenylguanidinobenzoate, an inhibitor of Plg activator and plasmin. These results suggested that the Plg activator secreted by the macrophages generated plasmin, which selectively degraded BP. This interpretation was confirmed by the observation that urokinase, a Plg activator, plus Plg was effective in degrading BP in myelin. We propose that the action of neutral proteinases released by stimulated macrophages, and its amplification by the Plg-plasmin system, may play a significant role in several inflammatory demyelinating diseases; and that the relative specificity of these reactions for myelin lies in the extreme susceptibility of BP to proteolysis.
在炎性脱髓鞘疾病中,如多发性硬化症、兰德里 - 古兰 - 巴雷综合征和实验性过敏性脑脊髓炎,脱髓鞘发生在浸润的单核细胞附近。尽管每种疾病的组织病理学特征不同,但炎症性病变中髓鞘破坏在吞噬作用之前就已开始这一普遍观察结果表明,这些疾病中髓鞘溶解存在共同机制。最近的研究表明,受刺激的巨噬细胞会分泌几种中性蛋白酶,包括纤溶酶原(Plg)激活剂。我们测试了这些蛋白酶是否能直接或间接引发髓鞘破坏的可能性。将分离的脑髓鞘与受刺激的小鼠腹腔巨噬细胞培养物的上清液在有和没有Plg的情况下孵育。单独的细胞上清液会导致髓鞘中碱性蛋白(BP)的一些降解。在有Plg的情况下,降解量显著增加。其他髓鞘蛋白基本保持完整。虽然已知能抑制中性蛋白酶的EDTA可消除上清液中不依赖Plg的蛋白水解活性,但纤溶酶原激活剂和纤溶酶的抑制剂对硝基苯基胍基苯甲酸可抑制依赖Plg的水解。这些结果表明,巨噬细胞分泌的Plg激活剂产生了纤溶酶,纤溶酶选择性地降解了BP。观察到纤溶酶原激活剂尿激酶加Plg能有效降解髓鞘中的BP,这一结果证实了上述解释。我们提出,受刺激的巨噬细胞释放的中性蛋白酶的作用及其通过Plg - 纤溶酶系统的放大作用,可能在几种炎性脱髓鞘疾病中起重要作用;并且这些反应对髓鞘的相对特异性在于BP对蛋白水解的极度敏感性。